The Use of Recombinant Human Bone Morphogenic Protein-2 (rhBMP-2) in Treatment for Cysts of the Oral and Maxillofacial Regions

The purpose of this study is to report on five cases treated with bone graft using recombinant human bone morphogeneticprotein-2 (rhBMP-2) on jaw defects after cyst enucleation. We performed bone graft with BMP (rhBMP-2+β-tricalcium phosphate/hydroxyapatite) wrapped with a collagen sponge on jaw def...

Full description

Saved in:
Bibliographic Details
Published inMaxillofacial plastic and reconstructive surgery pp. 25 - 29
Main Authors 이종범, 김택우, 류석환, 신동윤, 류현호, 박석용, 신영조, 김복주, 김철훈, 황희승
Format Journal Article
LanguageEnglish
Published 대한악안면성형재건외과학회 01.01.2014
Subjects
Online AccessGet full text
ISSN2288-8586
DOI10.14402/jkamprs.2014.36.1.25pISSN:1225-4207eISSN:2233-7296

Cover

More Information
Summary:The purpose of this study is to report on five cases treated with bone graft using recombinant human bone morphogeneticprotein-2 (rhBMP-2) on jaw defects after cyst enucleation. We performed bone graft with BMP (rhBMP-2+β-tricalcium phosphate/hydroxyapatite) wrapped with a collagen sponge on jaw defects after cyst enucleation. Postoperative panoramic radiographswere taken periodically. After 1 to 12 months, bone remodeling was observed in the jaw defect area. In our cases, therewere few signs or symptoms of recurrence of the cyst during the follow-up period. KCI Citation Count: 1
Bibliography:G704-000377.2014.36.1.003
06(025-029)JKAMPRS-13-038(이종범,김철훈)
ISSN:2288-8586
DOI:10.14402/jkamprs.2014.36.1.25pISSN:1225-4207eISSN:2233-7296